menu
    • menu

    Company profile for GSK

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At GSK we have a challenging mission: to improve the quality of human life by enabling people to do more, feel better, live longer. Find out how this shapes everything we do, including our R&D, our partnerships, our work with communities and our efforts to prevent and treat disease around the world. We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The...
    At GSK we have a challenging mission: to improve the quality of human life by enabling people to do more, feel better, live longer. Find out how this shapes everything we do, including our R&D, our partnerships, our work with communities and our efforts to prevent and treat disease around the world. We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GSKunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    980 Great West Road, Brentford, Middlesex TW8 9GS England
    Telephone
    Telephone
    +44 (0)20 8047 5000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gsk.com:443/en-gb/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1293

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour Global Ally in the Pharmaceutical IndustryYour Global Ally in the Pharmaceutical Industry

    Your Global Ally in the Pharmaceutical Industry
    Your Global Ally in the Pharmaceutical Industry

    reelYour Global Ally in the Pharmaceutical Industry

    This PharmaReel highlights Gentec Pharmaceutical's expertise in generic APIs, HPAPIs, and prostaglandins with more than 30 years of experience. Operating from EU-GMP-certified facilities, the company exports to over 70 countries worldwide.

    Impressions: 99

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 233

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

    #PharmaFlow by PHARMACOMPASS
    10 Jul 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    NPPA Notifies Separate Retail Price of GSK's Cold Medicine
    NPPA Notifies Separate Retail Price of GSK's Cold Medicine

    08 Jul 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=178948&sid=1

    PHARMABIZ
    08 Jul 2025
    Share Share
    US Senator Probes GSK's Halt of Children's Asthma Inhaler
    US Senator Probes GSK's Halt of Children's Asthma Inhaler

    28 Jun 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/us-senator-investigates-gsk-pulling-childrens-asthma-inhaler-2025-06-27/

    REUTERS
    28 Jun 2025
    Share Share
    Bharat, GSK to halve price of malaria vaccine by 2028
    Bharat, GSK to halve price of malaria vaccine by 2028

    26 Jun 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/gsk-bharat-biotech-slash-price-first-malaria-vaccine-less-5-2028

    FIERCE PHARMA
    26 Jun 2025
    Share Share
    FDA Approved Benlysta Autoinjector for Kids with Lupus Nephritis
    FDA Approved Benlysta Autoinjector for Kids with Lupus Nephritis

    24 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250623981547/en/FDA-approves-Benlysta-belimumab-Autoinjector-for-children-with-active-lupus-nephritis

    BUSINESSWIRE
    24 Jun 2025
    Share Share
    GSK`s Biologics Benlysta Receives Suppl Approval in US
    GSK`s Biologics Benlysta Receives Suppl Approval in US

    20 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761043

    FDA
    20 Jun 2025
    Share Share
    GSK Offloads Shigella Vaccine to Bharat Biotech Ahead of Phase 3
    GSK Offloads Shigella Vaccine to Bharat Biotech Ahead of Phase 3

    14 Jun 2025

    // PRESS RELEASE

    https://www.gsk.com/en-gb/media/press-releases/gsk-licenses-shigella-vaccine-candidate-to-bharat-biotech-for-continued-development/

    PRESS RELEASE
    14 Jun 2025
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Cefuroxime Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Cefuroxime Sodium

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24411

    Submission : 2011-03-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-208 - Rev 00

    Issue Date : 2013-07-02

    Type : Chemical

    Substance Number : 992

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Fluticasone Propionate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Fluticasone Propionate

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 31534

    Submission : 2017-04-11

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-229 - Rev 03

    Issue Date : 2025-04-25

    Type : Chemical

    Substance Number : 1750

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63379-001

    Start Marketing Date : 2014-04-18

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Amoxicillin Trihydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Amoxicillin Trihydrate

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13201

    Submission : 1998-04-30

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2000-010 - Rev 06

    Issue Date : 2024-11-25

    Type : Chemical

    Substance Number : 260

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Ilsung IS Co., Ltd.

    Registration Date : 2011-10-28

    Registration Number : 20050831-30-A-64-05(1)

    Manufacturer Name : Beecham Pharmaceuticals (Pte) Ltd

    Manufacturer Address : 38 Quality Road Jurong Industrial Estate, Singapore 618809

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Amoxicillin Trihydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Amoxicillin Trihydrate

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13207

    Submission : 1998-04-30

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2015-064 - Rev 01

    Issue Date : 2024-10-24

    Type : Chemical

    Substance Number : 260

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : GlaxoSmithKline Inc.

    Registration Date : 2005-08-31

    Registration Number : 20050831-30-A-64-05

    Manufacturer Name : Beecham Pharmaceuticals (Pte) Ltd

    Manufacturer Address : 38 Quality Road Jurong Industrial Estate, Singapore 618809

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Betamethasone Valerate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Betamethasone Valerate

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4578

    Submission : 1982-06-09

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2002-219 - Rev 09

    Issue Date : 2024-10-25

    Type : Chemical

    Substance Number : 811

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Ceftazidime

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Ceftazidime

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13650

    Submission : 2000-08-10

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2004-306 - Rev 01

    Issue Date : 2013-07-02

    Type : Chemical

    Substance Number : 1405

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Clavulanic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Clavulanic Acid

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4349

    Submission : 1981-12-02

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1999-113 - Rev 04

    Issue Date : 2014-02-26

    Type : Chemical

    Substance Number : 1140

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : GlaxoSmithKline Inc.

    Registration Date : 2020-03-10

    Registration Number : 20200310-113-F-91-24

    Manufacturer Name : SmithKline Beecham Pharmaceuticals

    Manufacturer Address : Shewalton Road, Irvine, KA11 5AP United Kingdom

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Clavulanic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Clavulanic Acid

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5701

    Submission : 1985-02-13

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-244 - Rev 01

    Issue Date : 2017-12-01

    Type : Chemical

    Substance Number : 1653

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Ilsung IS Co., Ltd.

    Registration Date : 2011-12-09

    Registration Number : 20090227-113-F-18-13(1)

    Manufacturer Name : SmithKline Beecham Pharmaceuticals

    Manufacturer Address : Shewalton Road GB-KA11 5AP Irvine Ayrshire

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Clavulanic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Clavulanic Acid

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 7048

    Submission : 1987-07-09

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1999-111 - Rev 04

    Issue Date : 2024-11-13

    Type : Chemical

    Substance Number : 1140

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Ilsung IS Co., Ltd.

    Registration Date : 2011-12-09

    Registration Number : 20090227-113-F-19-12(1)

    Manufacturer Name : SmithKline Beecham PLC

    Manufacturer Address : Clarendon road Worthing West Sussex BN14 8QH

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Clobetasol Propionate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    EPS
    Not Confirmed
    arrow

    Clobetasol Propionate

    United Kingdom

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    EPS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25444

    Submission : 2012-12-20

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2011-034 - Rev 04

    Issue Date : 2024-10-24

    Type : Chemical

    Substance Number : 2127

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : GlaxoSmithKline Inc.

    Registration Date : 2012-03-23

    Registration Number : 20120323-93-E-99-05

    Manufacturer Name : Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations)

    Manufacturer Address : Cobden Street, Montrose, Angus, DD10 8EA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Amoxicillin trihydrate

    CEP/COS

    EPS
    Not Confirmed
    arrow

    02

    Amoxicillin trihydrate, Enzymatic proces...

    CEP/COS

    EPS
    Not Confirmed
    arrow

    03

    Beclometasone dipropionate

    CEP/COS

    EPS
    Not Confirmed
    arrow

    04

    Betamethasone valerate, Micronised

    CEP/COS

    EPS
    Not Confirmed
    arrow

    05

    Betamethasone valerate, Micronised

    CEP/COS

    EPS
    Not Confirmed
    arrow

    06

    Ceftazidime Pentahydrate

    CEP/COS

    EPS
    Not Confirmed
    arrow

    07

    Cefuroxime axetil

    CEP/COS

    EPS
    Not Confirmed
    arrow

    08

    Cefuroxime sodium, Sterile

    CEP/COS

    EPS
    Not Confirmed
    arrow

    09

    Clobetasol propionate

    CEP/COS

    EPS
    Not Confirmed
    arrow

    10

    Clobetasol propionate, Montrose site

    CEP/COS

    EPS
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact GlaxoSmithKline and get a quotation

    GlaxoSmithKline is a supplier offers 142 products (APIs, Excipients or Intermediates).

    Find a price of Cefuroxime Sodium bulk with DMF, CEP offered by GlaxoSmithKline

    Find a price of Fluticasone Propionate bulk with DMF, CEP offered by GlaxoSmithKline

    Find a price of Amoxicillin Trihydrate bulk with CEP offered by GlaxoSmithKline

    Find a price of Betamethasone Valerate bulk with CEP offered by GlaxoSmithKline

    Find a price of Ceftazidime bulk with CEP offered by GlaxoSmithKline

    Find a price of Clavulanic Acid bulk with CEP offered by GlaxoSmithKline

    Find a price of Clobetasol Propionate bulk with CEP offered by GlaxoSmithKline

    Find a price of Salbutamol Sulphate bulk with CEP offered by GlaxoSmithKline

    Find a price of Ceftazidime bulk with DMF offered by GlaxoSmithKline

    Find a price of Cefuroxime Axetil bulk offered by GlaxoSmithKline

    Find a price of Clavulanic Acid bulk offered by GlaxoSmithKline

    Find a price of Fluticasone Furoate bulk with DMF offered by GlaxoSmithKline

    Find a price of Fluticasone Propionate bulk with DMF offered by GlaxoSmithKline

    Find a price of Griseofulvin bulk offered by GlaxoSmithKline

    Find a price of Labetalol Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Mupirocin Calcium bulk offered by GlaxoSmithKline

    Find a price of Paroxetine Hydrochloride bulk with DMF offered by GlaxoSmithKline

    Find a price of Salbutamol Sulphate bulk with DMF offered by GlaxoSmithKline

    Find a price of Salmeterol Xinafoate bulk with DMF offered by GlaxoSmithKline

    Find a price of Umeclidinium Bromide bulk with DMF offered by GlaxoSmithKline

    Find a price of Vilanterol Trifenatate bulk with DMF offered by GlaxoSmithKline

    Find a price of Live attenuated mumps bulk bulk with JDMF offered by GlaxoSmithKline

    Find a price of 6-Aminopenicillanic Acid bulk offered by GlaxoSmithKline

    Find a price of Albendazole bulk offered by GlaxoSmithKline

    Find a price of Amoxicillin Sodium bulk offered by GlaxoSmithKline

    Find a price of Amoxicillin Trihydrate bulk offered by GlaxoSmithKline

    Find a price of Ampicillin bulk offered by GlaxoSmithKline

    Find a price of Ampicillin Sodium bulk offered by GlaxoSmithKline

    Find a price of Ampicillin Trihydrate bulk offered by GlaxoSmithKline

    Find a price of Auranofin bulk offered by GlaxoSmithKline

    Find a price of Beclomethasone Dipropionate bulk offered by GlaxoSmithKline

    Find a price of Betamethasone Dipropionate bulk offered by GlaxoSmithKline

    Find a price of Betamethasone Valerate bulk offered by GlaxoSmithKline

    Find a price of Calcitonin bulk offered by GlaxoSmithKline

    Find a price of Caramiphen Ethanedisulfonate bulk offered by GlaxoSmithKline

    Find a price of Carbenicillin Indanyl bulk offered by GlaxoSmithKline

    Find a price of Cephalexin bulk offered by GlaxoSmithKline

    Find a price of Cephalosporin bulk offered by GlaxoSmithKline

    Find a price of Cephradine bulk offered by GlaxoSmithKline

    Find a price of Chlorpheniramine Maleate bulk offered by GlaxoSmithKline

    Find a price of Cimetidine bulk offered by GlaxoSmithKline

    Find a price of Clobetasol Propionate bulk offered by GlaxoSmithKline

    Find a price of Clobetasone Butyrate bulk offered by GlaxoSmithKline

    Find a price of Cloxacillin Benzathine bulk offered by GlaxoSmithKline

    Find a price of Cloxacillin Sodium bulk offered by GlaxoSmithKline

    Find a price of Deoxyuridine bulk offered by GlaxoSmithKline

    Find a price of Diethylcarbamazine Citrate bulk offered by GlaxoSmithKline

    Find a price of Diphenidol bulk offered by GlaxoSmithKline

    Find a price of Diphenylpyraline bulk offered by GlaxoSmithKline

    Find a price of Dopamine bulk offered by GlaxoSmithKline

    Find a price of Doxepin Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Fondaparinux Sodium bulk offered by GlaxoSmithKline

    Find a price of Hydrochlorothiazide bulk offered by GlaxoSmithKline

    Find a price of Isopropamide Iodide bulk offered by GlaxoSmithKline

    Find a price of Liothyronine Sodium bulk offered by GlaxoSmithKline

    Find a price of Megestrol Acetate bulk offered by GlaxoSmithKline

    Find a price of Methicillin bulk offered by GlaxoSmithKline

    Find a price of Mupirocin bulk offered by GlaxoSmithKline

    Find a price of Nafcillin Sodium bulk offered by GlaxoSmithKline

    Find a price of Oxacillin Sodium bulk offered by GlaxoSmithKline

    Find a price of Paroxetine Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Penicillin G Potassium bulk offered by GlaxoSmithKline

    Find a price of Propyliodone bulk offered by GlaxoSmithKline

    Find a price of Sodium Dicloxacillin bulk offered by GlaxoSmithKline

    Find a price of Streptokinase bulk offered by GlaxoSmithKline

    Find a price of Streptomycin bulk offered by GlaxoSmithKline

    Find a price of Sucralfate bulk offered by GlaxoSmithKline

    Find a price of Tetanus Immunoglobulin bulk offered by GlaxoSmithKline

    Find a price of Ticarcillin bulk offered by GlaxoSmithKline

    Find a price of Ticarcillin Monosodium bulk offered by GlaxoSmithKline

    Find a price of Tranylcypromine Sulfate bulk offered by GlaxoSmithKline

    Find a price of Trifluoperazine Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Vitamin B12 bulk offered by GlaxoSmithKline

    Find a price of Zidovudine bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CIDRA, PUERTO RICO. bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE AND FACILITIES FOR ANNAN, UK PLANT bulk offered by GlaxoSmithKline

    Find a price of 7-ACA TOSYLATE bulk offered by GlaxoSmithKline

    Find a price of FACILITIES AND MANUFACTURING bulk offered by GlaxoSmithKline

    Find a price of GENERAL OPERATING PROCEDURES SINGAPORE PLANT bulk offered by GlaxoSmithKline

    Find a price of CLENOLIXIMAB [CHIMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY (SB-217969) (CHO CELLS, SMITHKLINE BEECHAM) TO CD4] bulk offered by GlaxoSmithKline

    Find a price of COMPOUND 904 bulk offered by GlaxoSmithKline

    Find a price of L-DM1 bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING FACILITY AT VERONA, ITALY. bulk offered by GlaxoSmithKline

    Find a price of BUILDINGS AND FACILITIES IN SEALS SANDS, ENGLAND bulk offered by GlaxoSmithKline

    Find a price of ASO1B ADJUVANT SYSTEM bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING PRODUCTION FACILITY IN TORONTO, CANADA bulk offered by GlaxoSmithKline

    Find a price of MFG. SITE FACILITIES UTILIZED IN SPEKE LIVERPOOL (UK) bulk offered by GlaxoSmithKline

    Find a price of FACIL, PERSONNEL AND GENERAL OPERATING PROCEDURES IN HARLOW, ESSEX. bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CAROLINA, PUERTO RICO. bulk offered by GlaxoSmithKline

    Find a price of O/4 DIHYDROCHLORIDE DIHYRATE (CPZ ROUTE) bulk offered by GlaxoSmithKline

    Find a price of 0/4 DIHYDROCHLORIDE DIHYDRATE (CEPHALORIDINE ROUTE-CP)-ULVERSTON PLANT bulk offered by GlaxoSmithKline

    Find a price of FACILS AND GEN OPER PROCEDS AT THE ULVERSTON PLANT bulk offered by GlaxoSmithKline

    Find a price of SYNTHESIS & QUALITY CONTROLS FOR 5,7-DICHLORO-8-HYDROXYQUINOLONE bulk offered by GlaxoSmithKline

    Find a price of GENERAL OPERATING PROCEDURES FOR THE HEPPIGIES, BELGIUM--ANTIBIOTICS bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PESONNEL, AND GENERAL OPERATING PROCEDURES IN WEST SUSSEX, ENGLAND. bulk offered by GlaxoSmithKline

    Find a price of CHIMERIC (MACAQUE VARIABLE/HUMAN CONSTANT) (RECOMBINANT, CHO CELLS) MONOCLONAL ANTIBODY (SB 210396; CE9.1) TO HUMAN CD4 ANTIGEN bulk offered by GlaxoSmithKline

    Find a price of HIV VACCINE (GPL 120/NEFTA/ASO2A) bulk offered by GlaxoSmithKline

    Find a price of FACILITIES, METHODS AND CONTROLS bulk offered by GlaxoSmithKline

    Find a price of FACILITIES AND OPERATING PROCEDURES IN TIANJIN, CHINA bulk offered by GlaxoSmithKline

    Find a price of BRL 47539 (2-ACETOXYMETHYL-4-IODOBUT-1-YL-ACETATE) bulk offered by GlaxoSmithKline

    Find a price of MFG. FACILITIES LOCATED IN JURONG, SINGAPORE bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GREENVILLE, NORTH CAROLINA. bulk offered by GlaxoSmithKline

    Find a price of PENN CHEMICALS PRODUCTION FACILITY IN COUNTY CORK, IRELAND bulk offered by GlaxoSmithKline

    Find a price of FACIL, PERSONNEL & GENL OPER PROCED IN GREAT BURGH, EPSOM, U.K. bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TONBRIDGE, KENT, ENGLAND. bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN SINGAPORE bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MONTROSE, ANGEES, SCOTLAND. bulk offered by GlaxoSmithKline

    Find a price of FACILITIES&CONTROLS AT HARLOW AND GREAT BURGH RESEARCH SITES, ENGLAND bulk offered by GlaxoSmithKline

    Find a price of ENTRENOL bulk offered by GlaxoSmithKline

    Find a price of FACILITIES & CONTROLS OF THE WELLCOME FOUNDATION IN KENT ENGLAND bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BOMBAY, INDIA. bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by GlaxoSmithKline

    Find a price of MFGR, CONTROL PROCEDURES & FACILITIES-MYERSTOWN, PA., PLANT bulk offered by GlaxoSmithKline

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CUERNAVACA, MEXICO. bulk offered by GlaxoSmithKline

    Find a price of FACILITY IN BUCKHAVEN, UNITED KINGDOM bulk offered by GlaxoSmithKline

    Find a price of FACILITIES UTILIZED IN WARE HERTS, UNITED KINGDOM bulk offered by GlaxoSmithKline

    Find a price of FACILITY LOCATED IN EDINBURG, SCOTLAND bulk offered by GlaxoSmithKline

    Find a price of 'ZENTEL' 'TILTAB' TABLETS bulk offered by GlaxoSmithKline

    Find a price of Abacavir Sulfate bulk offered by GlaxoSmithKline

    Find a price of Benzyl Penicillin bulk offered by GlaxoSmithKline

    Find a price of Cabotegravir bulk offered by GlaxoSmithKline

    Find a price of Cabotegravir Sodium bulk offered by GlaxoSmithKline

    Find a price of CAS 103639-04-9 bulk offered by GlaxoSmithKline

    Find a price of Daprodustat bulk offered by GlaxoSmithKline

    Find a price of Dolutegravir Sodium bulk offered by GlaxoSmithKline

    Find a price of Dutasteride bulk offered by GlaxoSmithKline

    Find a price of Epsiprantel bulk offered by GlaxoSmithKline

    Find a price of Fluticasone Furoate bulk offered by GlaxoSmithKline

    Find a price of Lacidipine bulk offered by GlaxoSmithKline

    Find a price of Lamivudine bulk offered by GlaxoSmithKline

    Find a price of Nabumetone bulk offered by GlaxoSmithKline

    Find a price of Naratriptan Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Nelarabine bulk offered by GlaxoSmithKline

    Find a price of Ondansetron bulk offered by GlaxoSmithKline

    Find a price of Pazopanib Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Ranitidine Hydrochloride bulk offered by GlaxoSmithKline

    Find a price of Retapamulin bulk offered by GlaxoSmithKline

    Find a price of Trametinib bulk offered by GlaxoSmithKline

    Find a price of Umeclidinium Bromide bulk offered by GlaxoSmithKline

    Find a price of Vilanterol Trifenatate bulk offered by GlaxoSmithKline

    Find a price of Zanamivir bulk offered by GlaxoSmithKline

    Find a price of MEDICATED FEED bulk offered by GlaxoSmithKline

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search